CapsoVision Inc. Company Profile
NASDAQ: CVHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CapsoVision at a glance
CapsoVision Inc. (NASDAQ: CV) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company in the Health Care sector headquartered in Saratoga, CA. CapsoVision is led by Mr. Kang-Huai Wang and employs about 99 people. The company's shares have traded publicly since 2025.
At a market capitalization of $327.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001378325, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does CapsoVision do?
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Business description based on the company's public filings.
Company information
- Legal name
- CapsoVision Inc.
- Ticker
- NASDAQ: CV
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CEO
- Mr. Kang-Huai Wang
- Employees
- 99
- Headquarters
- 18805 Cox Avenue, Saratoga, CA, United States
- Phone
- 408 624 1488
- Website
- capsovision.com
- IPO year
- 2025
- Market cap
- $327.56M
- SEC CIK
- 0001378325
- Latest annual report
- 10-K · Mar 26, 2026
Companies similar to CapsoVision
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELMDElectromed Inc. | 22.98 | -1.20% | $187.84M | vs CV |
| FOCLEDAP TMS S.A. ADR | 2.61 | -7.45% | $123.25M | vs CV |
| VANIVivani Medical Inc. | 1.14 | +4.59% | $102.83M | vs CV |
| STXSStereotaxis Inc. | 0.9422 | -6.71% | $95.03M | vs CV |
| HSDTSolana Company Class A | 1.49 | -10.24% | $93.70M | vs CV |
| NRXSNeuraxis Inc. | 4.22 | -6.22% | $59.90M | vs CV |
| HYPRHyperfine Inc. Class A | 0.5465 | +4.27% | $57.96M | vs CV |
| OMOutset Medical Inc. | 2.81 | -3.44% | $53.03M | vs CV |